12 hrs ago
The Motley Fool
This Medical Marijuana Stock Is Not What You Think
Unlike many of the medical-marijuana companies producing and selling marijuana in states where it's legal, GW Pharmaceuticals isn't stuck in limbo where state laws permit the sale of marijuana but federal laws still say it's illegal.
Trending on the Topix Network
Fri Apr 18, 2014
Cornerstone to help Bayer's bee problem - Hack retires from GD,...
CORNERSTONE TO HELP BAYER'S BEE PROBLEM: Bayer Corporation has signed Cornerstone Government Affairs to help "pollinator health and habitat promotion" after a growing campaign, which includes reports from the European Union, has accused the chemical company of causing large-scale harm to the bee population with its pesticides.
Mon Apr 14, 2014
The Motley Fool
Why Is Regeneron Pharmaceuticals, Inc. Bucking the Downtrend?
Biotech stocks are awash in a sea of red for the most part right now. Turning to the gory details, 89% of biotechs finished in negative territory last week -- with the vast majority falling by double digits.
Bayer Corporation Launches New Educational Online Resource for...
The site www.CTEPH.com is designed to increase CTEPH disease awareness among healthcare professionals and educate them on proper CTEPH diagnosis and surgical treatment.
Courthouse News Service
Death Blamed on New Blood Thinner
Janssen Pharmaceuticals and Bayer "fervently marketed" an anticoagulant drug, Xarelto, "with no regard to the accuracy and misrepresentations of their misleading advertising," and without regard for reports of 356 serious, disabling or fatal injuries in a single quarter which it was the primary suspect, the heir of a woman who allegedly died from ... (more)
Fri Apr 11, 2014
Bayer Launches New Educational Online Resource for Chronic...
The site - www.CTEPH.com - is designed to increase CTEPH disease awareness among healthcare professionals and educate them on proper CTEPH diagnosis and surgical treatment.
Thu Apr 10, 2014
Bayer Moves to Eliminate Mirena IUD Claims
Bayer Healthcare Pharmaceuticals Inc. has moved to dismiss some of about 450 lawsuits filed over its Mirena intrauterine contraceptive device on ground that the cases exceed the applicable statute of limitations.
Customer Interaction Solutions
STEM Career Awareness Day April 11 for East Bay High School Students...
Half the nation's Fortune 1000 employers report being unable to find qualified graduates holding two- and four-year science degrees for a growing number of jobs in the STEM fields, according to a 2013 Bayer Facts of Science Education survey released by Bayer Corporation.
Wed Apr 09, 2014
Bayer USA Foundation Awards $600,000 to California State University East Bay
Foundation in 2011 to help establish the Institute as a center that addresses regional STEM education opportunities and challenges and encourages more underrepresented students to become the Bay Area's STEM workforce of tomorrow.
Wed Apr 02, 2014
Bayer Initiates Phase 3 Trial of XofigoA (radium Ra 223 dichloride)...
Bayer HealthCare Pharmaceuticals Inc. today announced that the company has begun to enroll patients in a trial studying Xofigo injection in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naive patients with bone predominant metastatic castration-resistant ... (more)
Bayer sells patents for carbon nanotubes and graphenes
Release date- 01042014 - Leverkusen - After concluding its research work on carbon nanotubes and graphenes, Bayer MaterialScience is divesting itself of fundamental intellectual property in this field.
Tue Apr 01, 2014
Bayer HealthCare AG To Dump $138 Million In Beijing Facility
The plant is expected to meet growing demand for Bayer's healthcare offerings, including products in the cardiovascular and diabetes sector.
Bayer nixes plan to discontinue drug for...
A major German drug maker called off its plan to discontinue the supply of a hemophiliac drug to the South Korean market in response to the fierce protests from patients, health authorities said Tuesday.
Mon Mar 31, 2014
Bayer gets EU approval for lung-disease drug
Bayer AG said Monday its pulmonary hypertension drug, Adempas, has been approved by the European Commission for the treatment of two chronic forms of hypertension, chalking up another approval for one of its five key drugs.
Fri Mar 28, 2014
Delhi High Court Bans Generic Medication Sorefenat
The Delhi High Court has temporarily banned the export of Sorefenat, a generic kidney and liver cancer medication.
Thu Mar 27, 2014
Auto market rebound drives business at Bayer's Robinson campus
A dramatic rebound in U.S. sales of new cars and trucks during the economic recovery is driving business and job growth at Bayer Corp.'s Robinson campus.
Wed Mar 26, 2014
Bayer donates $150K to Carnegie Science Center to support STEM programs
Bayer Corp. announced Wednesday it has awarded $150,000 to the Carnegie Science Center to support its science, technology, engineering and math programs.
Mon Mar 24, 2014
The Montgomery Advertiser
University's birth control research challenged
LOUIS -- A Washington University research project that provides free birth control to the poor and uninsured is under scrutiny for its off-label use of a contraceptive insert.